Myrexis, Inc. (MYRX)

USD 0.01

(0.0%)

Market Cap (In USD)

241.35 Thousand

Revenue (In USD)

-

Net Income (In USD)

-11.62 Million

Avg. Volume

1925.00

Currency
USD
Country
Financial Services
Open
-
Prev. Close
-
Day Range
-
Year Range
0.001-0.0192
PE
-
EPS
-
Beta Value
1.456
ISIN
US62856H1077
CUSIP
62856H107
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Financial Services
Industry
Shell Companies
CEO
Mr. Jonathan M. Couchman
Employee Count
-
Website
https://www.myrexis.com
Ipo Date
2009-06-12
Details
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.